Cambridge, UKJun 2022
Transine Therapeutics raised €16M in a Seed round in Jun 2022. The company is based in Cambridge, UK. Investors in the round: Dementia Discovery Fund (DDF), Epidarex Capital, Mary Canning. Data as of Nov 2026.
Amount raised
€16M
€16,087,743
Native amount
13,700,000 GBP
Stage
Seed
seed
Investors
3
Provenance & confidence
High confidenceAmount
13,700,000 GBP
ECB-at-date → €16M · rate 0.85158 on 2022-06-01
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
3 namedDate
Jun 2022
Round type
seed
Amount (EUR)
€16M
Other rounds
same companyThis is the company's only recorded round.
Related news
- Transine Therapeutics Closes £13.7M in Seed Fundingfinsmes.com · 2022-06